Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
Year-over-year research & development expense growth
Percentile
P17
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -42.51% |
| 2024 | -26.96% |
| 2023 | -44.84% |
| 2022 | -8.44% |
| 2021 | 619.59% |
| 2020 | 65.91% |
| 2019 | 0.00% |